<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To examine the utility of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> rubra vera-1 (PRV-1)-specific reverse transcriptase polymerase chain reaction (RT-PCR) to discriminate <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET) and <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) from secondary <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (ST) or secondary <z:hpo ids='HP_0001901'>erythrocytosis</z:hpo> (SE) </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: We analyzed the expression of PRV-1 in granulocytes isolated from 37 patients with ET, 37 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>, 25 patients with ST, 10 patients with SE, 25 patients with secondary <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> (SL), five patients with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), five patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (IM), five patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and 20 <z:mpath ids='MPATH_458'>normal</z:mpath> individuals by PRV-1-specific RT-PCR </plain></SENT>
<SENT sid="2" pm="."><plain>In female patients, PRV-1 expression was correlated with clonality analysis as assessed by the human <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor polymorphism assay </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: PRV-1 was not expressed in granulocytes isolated from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals or from patients with ST, SE, <z:mp ids='MP_0005481'>CML</z:mp>, IM, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and inflammatory/infectious SL </plain></SENT>
<SENT sid="4" pm="."><plain>On the contrary, <z:hpo ids='HP_0000001'>all</z:hpo> ET patients, 35 of 37 PV patients, and five patients with <z:hpo ids='HP_0011009'>acute</z:hpo> postsurgery and posttraumatic SL overexpressed PRV-1 </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the cases with monoclonal hematopoiesis (17 of 21 with ET and 12 of 12 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) expressed PRV-1, yet PRV-1 overexpression extended also over the cases of ET showing polyclonal hematopoiesis (four of 20) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The overexpression of PRV-1 seems to be a useful tool for discriminating ET and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> from ST and SE, thus offering an innovative diagnostic approach on the basis of the detection of positive diagnostic criteria instead of exclusion criteria </plain></SENT>
</text></document>